Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Restructuring Costs: 2020-2025

Historic Restructuring Costs for Aytu Biopharma (AYTU) over the last 4 years, with Jun 2025 value amounting to $2.1 million.

  • Aytu Biopharma's Restructuring Costs was N/A to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2025, which is 2.55% down from last year.
  • Per Aytu Biopharma's latest filing, its Restructuring Costs stood at $2.1 million for FY2025, which was down 2.55% from $2.2 million recorded in FY2024.
  • Aytu Biopharma's 5-year Restructuring Costs high stood at $4.9 million for FY2021, and its period low was $2.1 million during FY2025.
  • For the 2-year period, Aytu Biopharma's Restructuring Costs averaged around $2.1 million, with its median value being $2.1 million (2024).
  • Per our database at Business Quant, Aytu Biopharma's Restructuring Costs skyrocketed by 108.09% in 2021 and then fell by 2.55% in 2025.
  • Aytu Biopharma's Restructuring Costs (Yearly) stood at $4.9 million in 2021, then reached $2.2 million in 2024, then dropped by 2.55% to $2.1 million in 2025.